193 related articles for article (PubMed ID: 10591649)
1. Impaired immunoproteasome assembly and immune responses in PA28-/- mice.
Preckel T; Fung-Leung WP; Cai Z; Vitiello A; Salter-Cid L; Winqvist O; Wolfe TG; Von Herrath M; Angulo A; Ghazal P; Lee JD; Fourie AM; Wu Y; Pang J; Ngo K; Peterson PA; Früh K; Yang Y
Science; 1999 Dec; 286(5447):2162-5. PubMed ID: 10591649
[TBL] [Abstract][Full Text] [Related]
2. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
[TBL] [Abstract][Full Text] [Related]
3. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
[TBL] [Abstract][Full Text] [Related]
5. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
[TBL] [Abstract][Full Text] [Related]
6. [Advance in the study on the proteasome activator PA28].
Murata S; Chiba T
Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1832-40. PubMed ID: 10936967
[No Abstract] [Full Text] [Related]
7. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
Sijts A; Zaiss D; Kloetzel PM
Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
[TBL] [Abstract][Full Text] [Related]
8. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination.
Nussbaum AK; Rodriguez-Carreno MP; Benning N; Botten J; Whitton JL
J Immunol; 2005 Jul; 175(2):1153-60. PubMed ID: 16002717
[TBL] [Abstract][Full Text] [Related]
9. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.
Murata S; Udono H; Tanahashi N; Hamada N; Watanabe K; Adachi K; Yamano T; Yui K; Kobayashi N; Kasahara M; Tanaka K; Chiba T
EMBO J; 2001 Nov; 20(21):5898-907. PubMed ID: 11689430
[TBL] [Abstract][Full Text] [Related]
10. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region.
Shimbara N; Nakajima H; Tanahashi N; Ogawa K; Niwa S; Uenaka A; Nakayama E; Tanaka K
Genes Cells; 1997 Dec; 2(12):785-800. PubMed ID: 9544705
[TBL] [Abstract][Full Text] [Related]
11. The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context.
Kuckelkorn U; Ferreira EA; Drung I; Liewer U; Kloetzel PM; Theobald M
Eur J Immunol; 2002 May; 32(5):1368-75. PubMed ID: 11981824
[TBL] [Abstract][Full Text] [Related]
12. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
Rechsteiner M; Realini C; Ustrell V
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
[TBL] [Abstract][Full Text] [Related]
13. The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.
Groettrup M; Ruppert T; Kuehn L; Seeger M; Standera S; Koszinowski U; Kloetzel PM
J Biol Chem; 1995 Oct; 270(40):23808-15. PubMed ID: 7559557
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
15. The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.
Huang X; Seifert U; Salzmann U; Henklein P; Preissner R; Henke W; Sijts AJ; Kloetzel PM; Dubiel W
J Mol Biol; 2002 Nov; 323(4):771-82. PubMed ID: 12419264
[TBL] [Abstract][Full Text] [Related]
16. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
17. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.
Kloetzel PM
Nat Immunol; 2004 Jul; 5(7):661-9. PubMed ID: 15224091
[TBL] [Abstract][Full Text] [Related]
18. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
André P; Groettrup M; Klenerman P; de Giuli R; Booth BL; Cerundolo V; Bonneville M; Jotereau F; Zinkernagel RM; Lotteau V
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13120-4. PubMed ID: 9789051
[TBL] [Abstract][Full Text] [Related]
19. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.
Khan S; van den Broek M; Schwarz K; de Giuli R; Diener PA; Groettrup M
J Immunol; 2001 Dec; 167(12):6859-68. PubMed ID: 11739503
[TBL] [Abstract][Full Text] [Related]
20. Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing.
Yamano T; Murata S; Shimbara N; Tanaka N; Chiba T; Tanaka K; Yui K; Udono H
J Exp Med; 2002 Jul; 196(2):185-96. PubMed ID: 12119343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
